Markowski Investments’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
Markowski Investments's HQL Position: Q3 2026 in Review
Markowski Investments held its abrdn Life Sciences Investors (HQL) position steady in Q3 2026 at 105 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #591.
Markowski Investments first reported a position in HQL in Q2 2026 and has held it in 2 quarters since. The position peaked at $2.1K in Q2 2026. 83 funds tracked by Wall St. Rank hold HQL as of Q3 2026.
- Markowski Investments held 105 shares of abrdn Life Sciences Investors worth $1.96K as of Q3 2026.
- Markowski Investments left its abrdn Life Sciences Investors share count unchanged in Q3 2026.
- abrdn Life Sciences Investors made up ﹤0.01% of Markowski Investments's portfolio in Q3 2026, its #591 holding.
- Markowski Investments first reported a position in abrdn Life Sciences Investors in Q2 2026 and has held it in 2 quarters since.
- Markowski Investments's abrdn Life Sciences Investors position peaked at $2.1K in Q2 2026.
- 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.
Based on Markowski Investments's 13F filing for Q3 2026, filed 30 Oct 2026.